Open AccessInfluenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019–2020: A Test-Negative Study
Author(s) -
Carlos G Grijalva,
Leora R. Feldstein,
H. Keipp Talbot,
Michael S. Aboodi,
Adrienne Baughman,
Samuel M. Brown,
Jonathan D. Casey,
Heidi L. Erickson,
Matthew C. Exline,
D. Clark Files,
Kevin W. Gibbs,
Adit A. Ginde,
Michelle N. Gong,
Natasha Halasa,
Akram Khan,
Christopher J. Lindsell,
Samuel K. Nwosu,
Ithan D. Peltan,
Matthew E. Prekker,
Todd W. Rice,
Nathan I. Shapiro,
Jay S. Steingrub,
William B. Stubblefield,
Mark W Tenforde,
Manish Patel,
Wesley H. Self
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab462
Subject(s) - medicine , intensive care unit , interquartile range , vaccination , confounding , influenza vaccine , severity of illness , epidemiology , influenza like illness , pediatrics , immunology , virus
Influenza vaccine effectiveness (VE) against a spectrum of severe disease, including critical illness and death, remains poorly characterized.